Phenomex Inc (CELL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELL | AZN | AMGN | GILD | BMY |
| Company | Phenomex Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.9971 | 90.14 | 325.58 | 123.80 | 54.52 |
| High | 0.9995 | 91.11 | 331.34 | 126.24 | 54.91 |
| Low | 0.9970 | 89.17 | 321.71 | 122.28 | 53.88 |
| Latest | 0.9981 | 89.94 | 331.00 | 124.14 | 54.22 |
| Change | +0.0031 | -4.45 | +0.59 | -0.77 | -1.04 |
| % Change | +0.31% | -4.71% | +0.18% | -0.62% | -1.88% |
| Volume | 203,900 | 11,136,773 | 2,947,093 | 9,151,075 | 15,348,222 |
| 20-Day Average Volume | 773,645 | 8,078,134 | 2,763,070 | 6,573,589 | 14,221,331 |
| Previous Close | 0.9950 | 94.39 | 330.41 | 124.91 | 55.26 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9877 | 93.09 | 329.47 | 123.05 | 54.95 |
| 20-Day Raw Stochastic | 96.45% | 10.49% | 51.49% | 68.95% | 43.37% |
| 20-Day Relative Strength | 67.01 | 46.22 | 53.13 | 52.58 | 54.54 |
| Weighted Alpha | -73.82 | +31.07 | +21.09 | +29.45 | -0.28 |
| Today's Opinion | 24% Buy | 64% Buy | 80% Buy | 72% Buy | 80% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 64% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 8% Sell | 88% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 09/22/23 | -3.94% since 01/12/26 | +1.68% since 01/12/26 | +1.26% since 01/12/26 | -2.78% since 01/12/26 |
| Low | 0.9902 on 09/25/23 | 89.17 on 01/20/26 | 319.79 on 01/13/26 | 120.22 on 01/13/26 | 53.88 on 01/20/26 |
| High | 0.9995 on 09/29/23 | 96.43 on 01/14/26 | 333.03 on 01/16/26 | 126.24 on 01/20/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | +5.15% since 08/29/23 | -1.55% since 12/19/25 | +1.11% since 12/19/25 | -0.12% since 12/19/25 | +0.06% since 12/19/25 |
| Low | 0.9400 on 08/31/23 | 89.17 on 01/20/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 0.9995 on 09/29/23 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | +99.62% since 06/29/23 | +7.24% since 10/20/25 | +9.12% since 10/20/25 | +0.84% since 10/20/25 | +24.39% since 10/20/25 |
| Low | 0.3801 on 08/16/23 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 0.9995 on 09/29/23 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | -4.03% since 03/29/23 | +30.75% since 07/18/25 | +12.29% since 07/18/25 | +14.71% since 07/18/25 | +14.48% since 07/18/25 |
| Low | 0.3801 on 08/16/23 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 1.2685 on 04/21/23 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 99,108 | 292,780,416 | 177,919,520 | 154,973,344 | 112,495,712 |
| Shares Outstanding, K | 99,297 | 3,101,816 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 78,600,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -98,040,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 14,060,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -50,250,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 0.95 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 08/14/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 11/14/23 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 15.09 | 14.81 | 8.63 |